Technical Consultation on ‘Expanding the role of long-acting reversible contraception (LARC) in India’, 3rd Sept, 2021

The Centre for Contraception Research (CCR), a unit of ARTH, organized an online technical consultation on ‘Expanding the role of long-acting reversible contraception (LARC) in India’ on 3rd Sept, 2021.

The consultation was attended by around 55 participants including stakeholders and public health professionals involved in family planning including state NHM representatives, clinical practitioners, academicians from OBGYN departments of medical colleges, representatives of international agencies, non-governmental organizations and the pharmaceutical sector.

Various national and global experts shared their experience of introducing LARCs in a health system setting. Pilot  innovations were presented from India and Africa on PPIUCD, LNG-IUS and sub-dermal implant. Further, a panel discussion reflected on various factors affecting feasibility of expanding LARCs in India including policy & programme context, training and services, technology, costs and market; acceptability, choice and consent.

A video recording of the event can be accessed here.

A background brief with detailed information on LARCs and a summary report of the consultation are also available.